featured
PARP Inhibitors Improve Survival in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Cochrane Database of Systematic Reviews
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PARP (Poly ADP-Ribose Polymerase) Inhibitors for Locally Advanced or Metastatic Breast Cancer
Cochrane Database Syst Rev 2021 Apr 22;[EPub Ahead of Print], AM Taylor, DLH Chan, M Tio, SM Patil, TA Traina, ME Robson, M KhasrawFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.